Table 7.
Metronidazole Drug Interactions
| Drug | Cytochrome Association | ↑ Levels of CYP3A4 Substrates | Other Drug-Drug Interaction | Renal Impairment |
|---|---|---|---|---|
| Metronidazole | Inhibits CYP: 3A4 (moderate) 2C9 (weak) | benzodiazepines calcium channel blockers cyclosporine mirtazapine nateglinide nefazodone sildenafil (and other phosphodiesterase type 5 inhibitors) tacrolimus venlafaxine cisapride ergot alkaloids 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors (lovastatin, simvastatin) pimozide |
Cimetidine: increase levels of metronidazole Cisapride: proarrhythmic due to inhibition of metabolism Ethanol: disulfiram-like reactions Lithium: may increase lithium levels/toxicity Phenytoin, phenobarbital: may increase metabolism of metronidazole Warfarin: increases prothrombin time prolongation |
Inconsistent recommendations; consider dosage reduction in longerterm therapy with severe renal failure (CrCl <10 mL/minute) |
- CrCl
creatinine clearance.